4//SEC Filing
Voliotis Dimitris 4
Accession 0001725160-22-000035
CIK 0001725160other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 9:10 PM ET
Size
11.1 KB
Accession
0001725160-22-000035
Insider Transaction Report
Form 4
Voliotis Dimitris
SVP, Clinical Development
Transactions
- Award
Common Stock
2022-02-10+10,329→ 16,579 total - Award
Stock Option (Right to Buy)
2022-02-10+24,234→ 24,234 totalExercise: $52.61Exp: 2032-02-09→ Common Stock (24,234 underlying) - Sale
Common Stock
2022-02-14$50.16/sh−534$26,788→ 16,045 total - Sale
Common Stock
2022-02-14$50.75/sh−67$3,400→ 15,978 total
Footnotes (5)
- [F1]Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date.
- [F2]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
- [F3]The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.58 to $50.56. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.58 to $50.81. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001807910
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 9:10 PM ET
- Size
- 11.1 KB